Hopes new drug can help laminitis cases – but good management remains key

a laminitis stance
(Image credit: credit unknown)

A drug being used to treat horses suffering with acute laminitis is proving to be successful – but owners have been warned this does not mean they can become complacent in management practices.

Ertugliflozin, an SGL2 inhibitor used to help lower blood glucose levels in humans, has been found to lower insulin levels in horses, and is being used more in the treatment of laminitis and equine metabolic syndrome (EMS). The drug does not have marketing authorisation for use in horses, but it can be prescribed by a vet in the UK.

Becky Murray
Senior news writer

Since joining H&H in 2018, Becky has covered a broad range of equestrian news including welfare matters, veterinary studies, FEI Tribunal hearings and road safety campaigns. She has also interviewed top riders including Scott Brash, John Whitaker and Ian Stark, to name just a few. Becky’s reporting has taken her to Canada for Spruce Meadows and France for Pau five-star, as well as the Royal Highland and Blair Castle International Horse Trials closer to home. She was also a key part of the remote reporting team for the Tokyo Olympics and the Europeans.